Project Veritas released Part Two of its video series on the FDA today, which features FDA Executive Officer, Christopher Cole, speaking about the inner workings of the agency — including the FDA’s conflicts of interest, overspending, and why it’s hard for those within the agency to speak out on such abuses.
Here are some of the highlights from today’s video:
- FDA Executive Officer, Christopher Cole: “The drug companies, the food companies, the vaccine companies. So, they pay us hundreds of millions of dollars a year to hire and keep the reviewers to approve their products.”
- Cole on FDA fees: “Congress approved user fees for [the] FDA. Basically, we charge the industry millions of dollars in order to hire more drug reviewers and vaccine reviewers which will speed up the approval process. So, they [pharmaceutical companies] make more money.”
- Cole: “They [FDA] tone down the impact of the user fees on their operations because they know they’re dependent on the drug companies, and the vaccine companies, and these other companies for their agency to operate.”
- Cole on blowing the whistle: “There’s not an incentive to speak out in government, surprisingly. You would think there would be, but there’s not. It’s better just to just not say anything and just ignore it.”
You can watch the full video by HERE.
Cole’s LinkedIn page lists him as an Executive Officer within the agency’s Countermeasures Initiatives, which plays a critical role in ensuring that drugs, vaccines, and other measures to counter infectious diseases and viruses are safe. He made these revelations on a hidden camera to an undercover Project Veritas reporter.
A spokesperson for FDA issued a statement yesterday saying, “The person purportedly in the video does not work on vaccine matters and does not represent the views of the FDA.”
This statement appears to contradict a phone call released Wednesday afternoon by Project Veritas wherein Cole reiterated that he is “a manager in the office that helps oversee the approval of the COVID vaccines for emergency approval.”
Will the FDA clarify this situation? Only time will tell…
EDITORS NOTE: This Project Veritas video report is republished with permission. ©All rights reserved.